Emma Louise Jackson, CBiol MSB
Manager, REACH
 

 
T: +44 (0) 161 240 3839
 
Download vCard
 
EDUCATION:

BSc, Biomedical Sciences, University of the West of England, Bristol, 2002 (Honors)

 
 

PRINT

Emma Louise Jackson, The Acta Group’s (Acta®) Manager, REACH, is distinguished by more than a decade of experience in regulatory environments, assisting clients to achieve regulatory compliance in the United Kingdom (UK), the European Union (EU), the Americas, and Asia. She offers particular expertise in worldwide chemical notifications, data analysis, preparing test plans, and managing to completion large and complex compliance projects cost-effectively and harmoniously across multiple jurisdictions. Her focus is on compliance for industrial chemicals and chemical products.

Based in the UK, Ms. Jackson serves clients in the UK, EU, and worldwide. She offers regulatory advice on the EU Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), the UK’s domestic implementation of REACH (UK REACH), South Korea’s Act on Registration and Evaluation, Authorisation and Restriction of Chemical Substances (K-REACH), Taiwan’s Toxic Chemical Substances Control Act (TCSCA), the EU and UK Classification, Labelling and Packaging (CLP) Regulation, and chemical control measures in India, Malaysia, Australia, New Zealand, Japan, and China, among others. Clients rely on Acta specialists such as Ms. Jackson for review of classification and labeling of substances and mixtures, testing strategy advice, literature searching and reliability assessment, and compilation of regulatory documents, such as Chemical Safety Reports (CSR). She is an excellent resource for reviewing compliance with Safety Data Sheets (SDS), and she supports others in Acta in preparing SDSs and product labels and in liaising with various regulatory authorities in this regard.

As Manager, REACH, Ms. Jackson anticipates client needs by providing critical information necessary for intelligent business decisions. This value-added information allows clients to progress with their complex business arrangements. Previous to joining Acta, she was a regulatory manager at a large commercial laboratory.

Representative Engagements:

  • Assists clients with complex REACH projects, including one for a gas substance, by using many different methods, including read-across and expert statements, to ensure compliance and successful registration.
  • Assisted a global manufacturer of industrial and consumer products to maintain its supply in the UK after the UK’s departure from the EU.
  • Assisted with testing strategies for substances requiring registration in multiple countries to ensure compliance and therefore successful registration in all jurisdictions.
  • Reviewed existing product labels and SDSs (providing amendments as necessary) to ensure compliance for the EU and worldwide across a broad spectrum of substances, mixtures, and products.
  • Through REACH and CLP compliance audits, highlighted deficiencies and worked with the European Chemicals Agency (ECHA) and EU Member State Competent Authorities to achieve compliance swiftly and cost-effectively without supply chain disruption.
  • Liaised regularly with supply chains to ensure that regulatory information, critical for ensuring market and supply chain stability, is effectively and efficiently communicated to all applicable levels.

Publications:

Emma L. Jackson, Louise C. Boardall, Zameer Qureshi, "Top Questions for Substance Information Exchange Forum (SIEF) Participation," Elements, the Magazine of Chemicals Northwest, Summer, 2016.

A. Alwitry, E. Jackson, H. Chen, and R. Holden. “The Use of Surgical Facemasks during Cataract Surgery: Is It Necessary?,” British Journal of Ophthalmology. (2002) Sept. 86(9):975-977.

Speaking Engagements:

“Global Notification,” Chemicals Northwest REACH Users Group, Manchester, England (September 15, 2015).


 
THE ACTA GROUP
Beijing, China | Brussels, Belgium | Manchester, U.K. | Washington, D.C.
Contact • Twitter
 
Privacy Policy | Terms of Use | Cookie Policy
©2023 The Acta Group All Rights Reserved.